Newbridge Financial Services Group’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-434
Closed -$2.62K 1246
2024
Q1
$2.62K Sell
434
-918
-68% -$6.01K ﹤0.01% 973
2023
Q4
$9.49K Buy
1,352
+1,102
+441% +$8.56K ﹤0.01% 748
2023
Q3
$2.19K Buy
250
+50
+25% +$468 ﹤0.01% 1063
2023
Q2
$2.35K Hold
200
﹤0.01% 1116
2023
Q1
$3.43K Hold
200
﹤0.01% 1130
2022
Q4
$5.25K Hold
200
﹤0.01% 1056
2022
Q3
$20K Buy
200
+40
+25% +$5.41K 0.01% 701
2022
Q2
$23K Hold
160
0.01% 624
2022
Q1
$25K Hold
160
0.01% 665
2021
Q4
$35K Buy
+160
New +$31K 0.02% 573

Other funds holding TFFP

Newbridge Financial Services Group's TFFP Position: Q2 2024 in Review

Newbridge Financial Services Group sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q2 2024, closing a stake of 434 shares — an estimated $2.62K sold.

Newbridge Financial Services Group first reported a position in TFFP in Q4 2021 and held it in 10 quarters. The position peaked at $35K in Q4 2021. 21 funds tracked by Wall St. Rank hold TFFP as of Q2 2024.

  • Newbridge Financial Services Group reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 434 TFF Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $2.62K.
  • Newbridge Financial Services Group first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Newbridge Financial Services Group's TFF Pharmaceuticals, Inc. Common Stock position peaked at $35K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.